ARTICLE | Financial News
Genoa's series A brings in $62M
May 15, 2017 10:48 PM UTC
Pulmonary play Genoa Pharmaceuticals Inc. (Seattle, Wash.) said it raised $62 million in a series A financing led by F-Prime Capital Partners and Edmond de Rothschild Investment Partners. Also participating were Novo A/S (Hellerup, Denmark), RiverVest Venture Partners, and TPG Biotech.
The company expects to begin clinical studies this year of its lead candidate, Aerodone inhaled pirfenidone (formerly GP-101), and said the cash should fund its development through Phase II studies to treat idiopathic pulmonary fibrosis (IPF)...
BCIQ Company Profiles